Similar articles

• Class specific antinuclear antibodies in systemic lupus erythematosus.

  Savitri K, Sehgal S, Datta BN, Chugh KS. Savitri K, et al. Indian J Med Res. 1993 Feb;98:27-9. Indian J Med Res. 1993. PMID: 8495986
• [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].

  Boulila Elgaied A, Hintati B, Fakhfakh F, Karray H, Hachicha J, Jarraya A, Ayadi H. Boulila Elgaied A, et al. Tunis Med. 1993 Feb;71(2):91-5. Tunis Med. 1993. PMID: 8322428 French. No abstract available.
• Vascular complications in lupus nephritis and lupus-like syndromes.

  Seshan SV. Seshan SV. Wien Klin Wochenschr. 2000 Aug 25;112(15-16):687-91. Wien Klin Wochenschr. 2000. PMID: 11020958 Review. No abstract available.
• Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.

  Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M. Sinico RA, et al. Ann N Y Acad Sci. 2005 Jun;1050:193-200. doi: 10.1196/annals.1313.020. Ann N Y Acad Sci. 2005. PMID: 16014534
• [Anti-DNA antibodies: structure and pathogenic role].

  Ayed K. Ayed K. Arch Inst Pasteur Tunis. 2000;77(1-4):3-9. Arch Inst Pasteur Tunis. 2000. PMID: 14658221 Review. French.